Vanda Pharmaceuticals
VNDA
#8239
Rank
HK$2.44 B
Marketcap
HK$40.62
Share price
-3.36%
Change (1 day)
9.17%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Cash on Hand

Cash on Hand as of March 2026 : HK$1.58 Billion

According to Vanda Pharmaceuticals's latest financial reports the company has HK$1.58 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Vanda Pharmaceuticals - Cash on Hand chart (from 2005 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$2.05 B-29.42%
2024-12-31HK$2.90 B-4.08%
2023-12-31HK$3.03 B-16.87%
2022-12-31HK$3.64 B8.08%
2021-12-31HK$3.37 B18.38%
2020-12-31HK$2.85 B17.27%
2019-12-31HK$2.43 B20.62%
2018-12-31HK$2.01 B79.87%
2017-12-31HK$1.12 B2.23%
2016-12-31HK$1.09 B-1.24%
2015-12-31HK$1.10 B10.21%
2014-12-31HK$1.00 B-0.38%
2013-12-31HK$1.01 B8.31%
2012-12-31HK$0.93 B-19.29%
2011-12-31HK$1.15 B-24.97%
2010-12-31HK$1.54 B-3.18%
2009-12-31HK$1.59 B343.39%
2008-12-31HK$0.35 B-45.94%
2007-12-31HK$0.66 B167.92%
2006-12-31HK$0.24 B2.62%
2005-12-31HK$0.24 B91.16%
2004-12-31HK$0.12 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
HK$172.91 B 10,799.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$54.70 B 3,348.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$102.52 B 6,362.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$41.41 B 2,510.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$44.71 B 2,718.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$82.22 B 5,083.13%๐Ÿ‡บ๐Ÿ‡ธ USA